Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: Possible protective roles of natural antioxidant foods

Journal of Applied Toxicology

Volumn 26, Issue 1, 2006, Pages 42-46

  Çetin, Recep ^a   Devrim, Erdinç ^b   Kiliçoǧlu, Bülent ^c   Avci, Aslihan ^b   Çandir, Özden ^d   Durak, Ilker ^b  

^a Ankara Atatiirk Teaching and Research Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Ankara Education Research Hospital   (Turkey)

^d SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antioxidant foods; Cisplatin; Nephrotoxicity; Oxidative stress

Indexed keywords

ANTIOXIDANT; CATALASE; CISPLATIN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; RESVERATROL; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEMALE; GRAPE; KIDNEY PARENCHYMA; NEPHROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; TOMATO;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CATALASE; CISPLATIN; FEMALE; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY DISEASES; LYCOPERSICON ESCULENTUM; MALONDIALDEHYDE; OXIDATION-REDUCTION; PROTECTIVE AGENTS; RATS; RATS, WISTAR; VITIS; XANTHINE OXIDASE;

ANIMALIA; LYCOPERSICON ESCULENTUM; VITIS SP.;

EID: 31644444570     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1103     Document Type: Article

References (37)

1. Aebi H. 1974. Catalase. In Methods of Enzymatic Analysis, Bergmeyer HU (ed.). Academic Press: New York; 673-677.
2. Agarwall S, Rao AV. 2000. Tomato lycopene and its role in human health and chronic diseases. JAMC 163: 739-744.
3. Alcolea JF, Cano A, Acosta M, Arnao MB. 2002. Hydrophilic and lipophilic antioxidant activities of grapes. Nahrung 46: 353-356.
4. Appenroth D, Fröb S, Kersten L, Splinter EK, Winnefeld K. 1997. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch. Toxicol. 71: 677-683.
5. Baldew G, van den Hamer CJA, Los G, Vermeulen NPE, Goeij JJM, McVie JG. 1989. Selenium-induced protection against cis-diamminedichloroplatinum (II) nephrotoxicity in mice and rats. Cancer Res. 49: 3020-3023.
6. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. 1998. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 53: 394-401.
7. Bertelli AA, Migliori M, Panichi V, Origlia N, Filippi C, Das DK, Giovannini L. 2002. Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann. NY Acad. Sci. 957: 230-238.
8. Bogin E, Marom M, Levi Y. 1994. Changes in serum; liver and kidneys of cisplatin-treated rats; effects of antioxidants. Eur. J. Clin. Chem. Clin. Biochem. 32: 843-851.
9. Dahle LK, Hill EG, Hollman RT. 1962. The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arch. Biochem. Biophys. 98: 253-261.
10. Dasgupta A, Zdunek T. 1992. In vitro lipid peroxidation of human serum catalyzed by cupric ion: antioxidant rather than prooxidant role of ascorbate. Life Sci. 50: 875-882.
11. Davis CA, Nick HS, Agarwal A. 2001. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J. Am. Soc. Nephrol. 12: 2683-2690.
12. Durak İ, Canbolat O, Kavutcu M, Öztürk HS, Yurtarslani Z. 1996. Activities of total; cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J. Clin. Lab. Anal. 10: 17-20.
13. Durak İ, Karabacak H, Büyükkoçak S, Çimen MY, Kaçmaz M, Ömeroǧlu E, Öztürk HS. 1998. Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 78: 207-211.
14. Durak İ, Ozbek H, Karaayvaz M, Ozturk HS. 2002. Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem. Toxicol. 25: 1-8.
15. 4. Redox Report 8: 47-50.
16. Hannemann J, Baumann K. 1988. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex, different effects of antioxidants and radical scavengers. Toxicology 51: 119-132.
17. Hashimato S. 1974. A new spectrophotometric assay method of xanthine oxidase in crude tissue homogenate. Anal. Biochem. 62: 425-435.
18. Kavutcu M, Canbolat O, Öztürk S, Olcay E, Ulutepe S, Ekinci C, Gokhun IH, Durak I. 1996. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs, effects of vitamins E and C. Nephron 72: 269-274.
19. Khyniram D, Prasad SB. 2002. Changes in glutathione-related enzymes in tumor-bearing mice after cisplatin treatment. Cell. Biol. Toxicol. 18: 349-358.
20. Kruidering M, van de Water B, de Heer E, Mulder GJ, Nagelkerke JF. 1997. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells, mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J. Pharmacol. Exp. Ther. 280: 638-649.
21. Lebwohl D, Canetta R. 1998. Clinical development of platinum complexes in cancer therapy: An historical perspective and an update. Eur. J. Cancer 34: 1522-1534.
22. Linder N, Rapola J, Raivio KO. 1999. Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab. Invest. 79: 967-974.
23. Lowry O, Rosebrough N, Farr L, Randall R. 1951. Protein measurement with folin phenol reagent. J. Biol. Chem. 193: 265-275.
24. Masuda H, Tanaka T, Takahama U. 1994. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem. Biophys. Res. Commun. 203: 1175-1180.
25. Matsushima H, Yonemura K, Ohishi K, Hishida A. 1998. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J. Lab. Clin. Med. 131: 518-526.
26. McManaman JL, Bain DL. 2002. Structural and conformational analysis of the oxidase to dehydrogenase conversion of xanthine oxidoreductase. J. Biol. Chem. 277: 21261-21268.
27. Mora L de O, Antunes LM, Francescato HD, Bianchi M de L. 2003. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol. Res. 47: 517-522.
28. Ozturk HS, Kacmaz M, Cimen MY, Durak I. 1999. Red wine and black grape strengthen blood antioxidant potential. Nutrition 15: 954-955.
29. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70: 158-169.
30. Sadzuka Y, Shoji T, Takino Y. 1992. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem. Pharmacol. 43: 1873-1875.
31. Stahl W, Sies H. 1996. Lycopene: a biologically important carotenoid for humans? Arch. Biochem. Biophys. 336: 1-9.
32. Ulubas B, Cimen MY, Apa DD, Saritas E, Muslu N, Cimen OB. 2003. The protective effects of acetylsalicylic acid on free radical production in cisplatin induced nephrotoxicity: an experimental rat model. Drug Chem. Toxicol. 26: 259-270.
33. Visioli F, Riso P, Grande S, Gali C, Porrini M. 2003. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur. J. Nutr. 42: 201-206.
34. Weisburger JH. 2002. Lycopene and tomato products in health promotion. Exp. Biol. Med. 227: 924-927.
35. Wolfgang GH, Dominick MA, Walsh KM, Hoeschele JD, Pegg DG. 1994. Comparative nephrotoxicity of a novel platinum compound. Cisplatin and carboplatin in male Wistar rats. Fundam. Appl. Toxicol. 22: 73-79.
36. Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, Akyol O. 2003. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol. Res. 47: 149-156.
37. Zhang JG, Lindup WE. 1993. Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slides. Biochem. Pharmacol. 45: 2215-2222.